621 Real World Study

Not Applicable

Recruiting

• Conditions: Senile Cataract
• Interventions: Device: Cataract surgery

• Registration Number: NCT05646004
• Lead Sponsor: Carl Zeiss Meditec AG

Brief Summary

This study is evaluating the clinical safety and effectiveness of 621, after cataract surgery.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-12-02
• Study First Submitted QC: 2022-12-02
• Study First Posted: 2022-12-12
• Status Verified: 2023-01
• Study Start: 2023-01-09
• Last Update Submitted: 2023-01-09
• Last Update Posted: 2023-01-10
• Primary Completion: 2024-09-01
• Study Completion: 2024-09-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
621	Cataract surgery	-

Primary Outcome Measures

Name	Time	Method
Corrected Distance Visual Acuity (CDVA)	6 months	measurement of CDVA after IOL implantation

Trial Locations

Locations (1)

Hainan Boao Lecheng Aier Eye Hospital; 🇨🇳 Qionghai, Hainan, China